Last reviewed · How we verify

NCT03859167: SLAVSME

Study of the Loss of AV Synchrony at Maximum Exercise

Terminated Last updated 14 April 2023
What this trial tests

trial testing Stress Test in Exercise in 9 participants. Terminated before completion.

Timeline
10 September 2019
Primary endpoint
10 April 2023
10 April 2023

Quick facts

Lead sponsorVanderbilt University Medical Center
StatusTerminated
Study typeOBSERVATIONAL
Enrollment9
Start date10 September 2019
Primary completion10 April 2023
Estimated completion10 April 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 18 to 60, any sex, with Exercise or Pacemaker. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will identify a group of patients with complete heart block and a dual chamber pacemaker who will be expected to be able to exercise on a treadmill. Investigators will utilize symptom logs, cuff and continuous blood pressure monitoring. It is planned to study the symptomatic impact of loss of AV synchrony at significant levels of exercise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Stress Test

Trials testing the same drug.

Other recruiting trials for Exercise

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859167.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing